Leukemia, Acute Lymphoblastic: Clinical Trials

2 trials for Leukemia, Acute Lymphoblastic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Leukemia, Acute Lymphoblastic: new trials by email Literature Review of Leukemia, Acute Lymphoblastic trials Research Report on Leukemia, Acute Lymphoblastic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL
CART 19 - Leukemia, Acute Lymphoblastic
Phase 2TerminatedUniversity of Pennsylvania12016-10-012023-06-22
Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT
Clofarabine, Cyclophosphamide, Etoposide - Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia
Phase 2TerminatedMedical College of Wisconsin62014-12-082020-03-09

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Leukemia, Myeloid, Acute (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Leukemia, Myeloid (1)

Interventions

Clofarabine (1)  ·  Cyclophosphamide (1)  ·  Etoposide (1)  ·  etoposide phosphate (1)

Sponsors

Medical College of Wisconsin (1)  ·  University of Pennsylvania (1)

Countries

United States (2)

Top investigators

Michael J Burke, MD (1)  ·  Noelle Frey, MD (1)